These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 19802982

  • 1. The in-vitro activity of three anti-pseudomonal cephalosporins against isolates from patients with cystic fibrosis.
    Kelly N, Falkiner FR, Keane CT, Murphy M, Fitzgerald MX.
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():175-8. PubMed ID: 19802982
    [Abstract] [Full Text] [Related]

  • 2. Activities of new beta-lactam antibiotics against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis.
    Prince AS, Neu HC.
    Antimicrob Agents Chemother; 1981 Oct; 20(4):545-6. PubMed ID: 6282199
    [Abstract] [Full Text] [Related]

  • 3. In-vitro activity of ceftazidime against Pseudomonas aeruginosa: and its stability to pseudomonal beta-lactamases.
    Livermore DM, Williams RJ, Williams JD.
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():163-7. PubMed ID: 19802980
    [Abstract] [Full Text] [Related]

  • 4. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
    Jones RN, Barry AL, Thornsberry C, Gerlach EH, Fuchs PC, Gavan TL, Sommers HM.
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
    [Abstract] [Full Text] [Related]

  • 5. The in-vitro activity of ceftazidime against clinically important pathogens.
    Knothe H, Dette GA.
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():33-41. PubMed ID: 19810167
    [Abstract] [Full Text] [Related]

  • 6. An in-vitro comparison of new cephalosporins with special reference to Pseudomonas aeruginosa.
    van Klingeren B.
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():97-105. PubMed ID: 19810171
    [Abstract] [Full Text] [Related]

  • 7. Ceftazidime: comparative in-vitro study.
    Verbist L, Verhaegen J.
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():67-71. PubMed ID: 19802971
    [Abstract] [Full Text] [Related]

  • 8. In-vitro activity of ciprofloxacin and other beta-lactam antibiotics against gentamicin- and carbenicillin-resistant isolates of Pseudomonas aeruginosa.
    Sofianou DC, Douboyas JP.
    J Chemother; 1991 Feb; 3(1):3-5. PubMed ID: 1902252
    [Abstract] [Full Text] [Related]

  • 9. Comparison of cefpiramide (HR-810) and four anti-pseudomonal beta-lactam agents against pseudomonas isolates from children with cystic fibrosis.
    Aronoff SC, Klinger JD.
    J Antimicrob Chemother; 1985 May; 15(5):545-9. PubMed ID: 3924879
    [Abstract] [Full Text] [Related]

  • 10. Alternative antibiotics for the treatment of Pseudomonas infections in cystic fibrosis.
    Mastella G, Agostini M, Barlocco G, Bonomi U, Borgo G, Bozzino L, Cabrini G, Cappelletti LM, Castellani L, Conforti M.
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():297-311. PubMed ID: 6311788
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the in-vitro activities of ceftazidime and new cephalosporins against 107 strains of Pseudomonas aeruginosa and 249 strains of cefazolin-resistant Enterobacteriaceae.
    Thabaut A, Durosoir JL, Saliou P.
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():123-5. PubMed ID: 19810174
    [Abstract] [Full Text] [Related]

  • 12. [Pseudomonas aeruginosa: acquired in vitro resistance to beta-lactams].
    Thabaut A, Meyran M.
    Pathol Biol (Paris); 1983 May; 31(5):387-91. PubMed ID: 6413939
    [Abstract] [Full Text] [Related]

  • 13. The in vitro activity of beta-lactam antibiotics against gentamicin and/or carbenicillin-resistant Pseudomonas aeruginosa strains.
    Aisa ML, Omenaca M, Bergua C, Garcia-Moya JB.
    Infection; 1982 May; 10 Suppl 3():S244-8. PubMed ID: 6818157
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the in vitro activity of new beta-lactams and aminoglycosides against clinical isolates of Pseudomonas aeruginosa.
    Patzer J, Gieburowska R, Dzierzanowska D.
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Oct; 253(1):110-20. PubMed ID: 6817544
    [Abstract] [Full Text] [Related]

  • 15. [Comparison of in vitro bacteriostatic effect of five betalactamins against Pseudomonas aeruginosa (author's transl)].
    Lesage D, Delisle-Mizon F, Denis C, Vergez P, Daguet GL.
    Pathol Biol (Paris); 1982 Jun; 30(6):440-3. PubMed ID: 6213917
    [Abstract] [Full Text] [Related]

  • 16. Activity of cephalosporin CXA-101 (FR264205) against Pseudomonas aeruginosa and Burkholderia cepacia group strains and isolates.
    Livermore DM, Mushtaq S, Ge Y, Warner M.
    Int J Antimicrob Agents; 2009 Nov; 34(5):402-6. PubMed ID: 19428220
    [Abstract] [Full Text] [Related]

  • 17. In vitro activity of ceftolozane-tazobactam and ceftazidime-avibactam against Pseudomonas aeruginosa isolated from patients with cystic fibrosis.
    Nolan PJ, Jain R, Cohen L, Finklea JD, Smith TT.
    Diagn Microbiol Infect Dis; 2021 Feb; 99(2):115204. PubMed ID: 33152675
    [Abstract] [Full Text] [Related]

  • 18. Cefoperazone against carbenicillin-resistant isolates of Pseudomonas aeruginosa: comparison with other newer cephalosporins and N-formimidoyl thienamycin.
    Chau PY, Ling J, Ng WS.
    J Antimicrob Chemother; 1983 Oct; 12(4):337-45. PubMed ID: 6417100
    [Abstract] [Full Text] [Related]

  • 19. In vitro activity of meropenem, imipenem, cefepime and ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Christenson JC, Korgenski EK, Daly JA.
    J Antimicrob Chemother; 2000 Jun; 45(6):899-901. PubMed ID: 10837448
    [Abstract] [Full Text] [Related]

  • 20. The in-vivo antibacterial activity of ceftazidime (Gr 20263)--a comparison with other new beta-lactam antibiotics and gentamicin.
    Acred P, Ryan DM, Sowa MA, Watts CM.
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():247-55. PubMed ID: 19802994
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.